Coherus Oncology, Inc. (CHRS) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Coherus Oncology, Inc. (CHRS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $208.7M, listed on NASDAQ, employing roughly 228 people, carrying a beta of 1.02 to the broader market. Coherus Oncology, Inc. Led by Dennis Lanfear, public since 2014-11-06.
Snapshot as of May 15, 2026.
- Spot Price
- $1.58
- Total OI
- 16.9K